Tech Company Financing Transactions

Aileron Therapeutics Funding Round

Aileron Therapeutics, based in Watertown, raised $40 million in funding from GlaxoSmithKline, SR One Capital Management and Apple Tree Partners.

Transaction Overview

Company Name
Aileron Therapeutics
Announced On
6/8/2009
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors

GlaxoSmithKline (Lead Investor)

SR One Capital Management (Lead Investor) (Michael Diem)

Apple Tree Partners (Seth Harrison)

Excel Medical Fund (Enrico Petrillo)

Lilly Ventures

Novartis Venture Fund (Campbell Murray)

Roche Venture Fund

Proceeds Purpose
Proceeds from the financing will be used to advance Aileron's lead Stapled Peptide program toward clinical trials in 2010 and to further advance the Stapled Peptide platform and programs in oncology, immune/inflammation, metabolic disease, and infectious disease.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
490 Arsenal Way
Watertown, MA 02472
USA
Phone
(617) 995-0900
Website
www.aileronrx.com
Email Address
[email protected]
Overview
Aileron Therapeutics (NASDAQ: ALRN) is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
Profile
Aileron Therapeutics LinkedIn Company Profile
Social Media
Aileron Therapeutics Company Twitter Account
Company News
Aileron Therapeutics News
Facebook
Aileron Therapeutics on Facebook
YouTube
Aileron Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Manuel Aivado
  Manuel Aivado LinkedIn Profile  Manuel Aivado Twitter Account  Manuel Aivado News  Manuel Aivado on Facebook
Chief Financial Officer
Donald Dougherty
  Donald Dougherty LinkedIn Profile  Donald Dougherty Twitter Account  Donald Dougherty News  Donald Dougherty on Facebook
Chief Medical Officer
Vojislav Vukovic
  Vojislav Vukovic LinkedIn Profile  Vojislav Vukovic Twitter Account  Vojislav Vukovic News  Vojislav Vukovic on Facebook
VP - Bus. Development
Kathryn Gregory
  Kathryn Gregory LinkedIn Profile  Kathryn Gregory Twitter Account  Kathryn Gregory News  Kathryn Gregory on Facebook
VP - R & D
Allen Annis
  Allen Annis LinkedIn Profile  Allen Annis Twitter Account  Allen Annis News  Allen Annis on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/8/2009: NextIO venture capital transaction
Next: 6/8/2009: Silicon Clocks venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.